|Articles|January 12, 2021
- Pharmaceutical Executive-01-01-2021
- Volume 41
- Issue 1
Pharmaceutical Executive, January 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
2021 in Focus: Pharm Exec’s Annual Industry Outlookover 5 years ago
Prescriber Hesitancy on COVID Vaccinesover 5 years ago
More Cloud on the Horizon for Pharmaover 5 years ago
A New Year for Sustainable Governanceover 5 years ago
Bound By Bloodover 5 years ago
Pharma in Spotlight as Pandemic Continues in 2021over 5 years ago
Six Degrees of 2020over 5 years ago
Why Investing in Tech Education Is Importantover 5 years ago
Pharm Exec Hits 40Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Regulatory Shifts are Impacting the Vaccine Environment
2
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
3
What Do You See as The Next Phase of Obesity Innovation?
4
Addressing Prohibitive Costs for Rare Diseases
5